Intech Investment Management LLC Has $171.75 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Intech Investment Management LLC boosted its position in UnitedHealth Group Incorporated (NYSE:UNH) by 1.0% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 337,254 shares of the healthcare conglomerate’s stock after purchasing an additional 3,348 shares during the quarter. UnitedHealth Group makes up 2.1% of Intech Investment Management LLC’s portfolio, making the stock its 7th biggest position. Intech Investment Management LLC’s holdings in UnitedHealth Group were worth $171,750,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the business. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 0.6% in the first quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock worth $41,755,280,000 after acquiring an additional 544,740 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in UnitedHealth Group by 0.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock valued at $12,893,331,000 after purchasing an additional 94,641 shares during the last quarter. Capital Research Global Investors raised its holdings in UnitedHealth Group by 2.2% in the fourth quarter. Capital Research Global Investors now owns 15,122,203 shares of the healthcare conglomerate’s stock worth $7,961,369,000 after buying an additional 324,733 shares during the last quarter. Capital International Investors grew its holdings in shares of UnitedHealth Group by 4.8% during the fourth quarter. Capital International Investors now owns 11,860,985 shares of the healthcare conglomerate’s stock valued at $6,244,158,000 after buying an additional 542,424 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after acquiring an additional 35,533 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.6 %

Shares of NYSE:UNH opened at $577.10 on Friday. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94. The company has a market cap of $532.91 billion, a PE ratio of 35.28, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The stock has a 50 day moving average of $575.84 and a 200 day moving average of $519.83. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The firm had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same period last year, the firm earned $6.14 EPS. The company’s revenue was up 6.4% on a year-over-year basis. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th will be paid a $2.10 dividend. The ex-dividend date is Monday, September 16th. This represents a $8.40 annualized dividend and a yield of 1.46%. UnitedHealth Group’s payout ratio is 51.34%.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on UNH shares. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a research note on Thursday, May 30th. Wells Fargo & Company raised their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and increased their price objective for the company from $481.00 to $647.00 in a research report on Wednesday, July 17th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Monday. Finally, Argus lifted their price objective on UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. One research analyst has rated the stock with a hold rating, nineteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average price target of $614.17.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the firm’s stock in a transaction that occurred on Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares of the company’s stock, valued at $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.